Programme
Thursday 13th November 2003
Registration
19.00 : Reception
20.00 : Dinner
Friday 14th November 2003
09.00-10.30 : Debate : The NSF strategy for retinal screening will not prevent blindness from diabetic retinopathy
Chairman : Dr Bob Ryder
For the motion : Professor Roy Taylor, Newcastle upon Tyne
Against the motion : Dr Peter Scanlon, Cheltenham
10.30-11.00 : Coffee
11.00-12.30 : Clinical Audit presentations
11.00-11.30 : Dr Ian Gallen, Wycombe Hospital:
Prospective audit of the introduction of insulin glargine (Lantus) into clinical practice in type 1 diabetic patients
11.30-12.00 : Dr David Levy, Whipps Cross Hospital: Experience with glitazones as triple oral therapy for type 2 diabetes
12.00-12.30 : Dr Colin Close, Taunton and Somerset Hospital : Treating hypertension in diabetic nephropathy
12.30-13.45 : Lunch
13.45-14.30 : Coagulopathy and diabetes - Beyond aspirin - Professor Peter Grant, Leeds
14.30-15.15 : HbA1c measurement - What the clinician needs to know - Dr Eric Kirkpatrick, Hull
15.15-16.00 : The Diabetes NSF - What is the role of the consultant physician-diabetologist - Dr Sue Roberts , National Clinical Director for Diabetes, Dept of Health
16.00 : Tea and conclusion of meeting
